Simrat Randhawa
Chief Tech/Sci/R&D Officer en DIANTHUS THERAPEUTICS, INC. .
Fortuna: 120 000 $ al 31/03/2024
Perfil
Simrat Randhawa is currently the Chief Medical Officer at Dianthus Therapeutics, Inc. Prior to this, he held the position of Head-Medical Affairs at BioMarin Pharmaceutical, Inc. He also served as the Senior Vice President-Clinical & Medical Affairs at Aurinia Pharmaceuticals, Inc. from 2019 to 2022.
Dr. Randhawa holds an MBA from The Trustees of Columbia University in The City of New York and a doctorate from Drexel University College of Medicine.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 01/04/2024 | 4 000 ( 0.01% ) | 120 000 $ | 31/03/2024 |
Cargos activos de Simrat Randhawa
| Empresas | Cargo | Inicio |
|---|---|---|
| DIANTHUS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 11/09/2023 |
Antiguos cargos conocidos de Simrat Randhawa.
| Empresas | Cargo | Fin |
|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Chief Tech/Sci/R&D Officer | 01/04/2022 |
| BIOMARIN PHARMACEUTICAL INC. | Chief Tech/Sci/R&D Officer | - |
Formación de Simrat Randhawa.
| The Trustees of Columbia University in The City of New York | Masters Business Admin |
| Drexel University College of Medicine | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| AURINIA PHARMACEUTICALS INC. | Health Technology |
| DIANTHUS THERAPEUTICS, INC. | Health Technology |
- Bolsa de valores
- Insiders
- Simrat Randhawa
